Journal article · 2013 · Open access
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
Gynecologic Oncology, 132(1), 8–17 · Published 15 November 2013 · DOI 10.1016/j.ygyno.2013.11.008
In brief
“Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper” is a 2013 journal article by Thomas J. Herzog and 10 co-authors, published in Gynecologic Oncology. OpenAlex counts 77 citations as of 22 November 2026. It is open access: the full text is free to read at Europe PMC (PubMed Central).
- Citations
- 77
- Most cited in
- 2016 (10)
- Field-weighted impact
- 4.77
- References
- 48
- Authors
- 11
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Herzog, T. J., Armstrong, D. K., Brady, M. F., Coleman, R. L., Einstein, M. H., Monk, B. J., Mannel, R. S., Thigpen, J. T., Umpierre, S. A., Villella, J., & Alvarez, R. D. (2013). Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper. Gynecologic Oncology, 132(1), 8–17. https://doi.org/10.1016/j.ygyno.2013.11.008
MLA 9
Herzog, Thomas J., et al. “Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper.” Gynecologic Oncology, vol. 132, no. 1, 2013, pp. 8–17. https://doi.org/10.1016/j.ygyno.2013.11.008.
Chicago
Herzog, Thomas J., Deborah Kay Armstrong, Mark F. Brady, Robert Louis Coleman, Mark H. Einstein, Bradley J. Monk, Robert S. Mannel, et al. 2013. “Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper.” Gynecologic Oncology 132 (1): 8–17. https://doi.org/10.1016/j.ygyno.2013.11.008.
Harvard
Herzog, T. J. et al. (2013) ‘Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper’, Gynecologic Oncology, 132(1), pp. 8–17. doi:10.1016/j.ygyno.2013.11.008.
IEEE
T. J. Herzog et al., “Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper,” Gynecologic Oncology, vol. 132, no. 1, pp. 8–17, 2013, doi: 10.1016/j.ygyno.2013.11.008.
BibTeX
@article{herzog2013ovarian,
title = {{Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper}},
author = {Herzog, Thomas J. and Armstrong, Deborah Kay and Brady, Mark F. and Coleman, Robert Louis and Einstein, Mark H. and Monk, Bradley J. and Mannel, Robert S. and Thigpen, James Tate and Umpierre, Sharee A. and Villella, Jeannine and Alvarez, Ronald David},
journal = {Gynecologic Oncology},
year = {2013},
volume = {132},
number = {1},
pages = {8--17},
doi = {10.1016/j.ygyno.2013.11.008},
url = {https://doi.org/10.1016/j.ygyno.2013.11.008}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2016 | 10 | |
| 2017 | 9 | |
| 2018 | 6 | |
| 2019 | 4 | |
| 2020 | 6 | |
| 2021 | 8 | |
| 2022 | 4 | |
| 2023 | 2 | |
| 2024 | 1 | |
| 2026 | 5 |
Its field-weighted citation impact is 4.77: it has been cited 4.77 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- ovarian cancer
- clinical trial endpoints
- overall survival
- progression-free survival
- patient-reported outcomes
- health-related quality of life
- regulatory approval
- post-progression therapy
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Herzog, T. J., Armstrong, D. K., Brady, M. F., Coleman, R. L., Einstein, M. H., Monk, B. J., Mannel, R. S., Thigpen, J. T., Umpierre, S. A., Villella, J., & Alvarez, R. D. (2013). Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper. Gynecologic Oncology, 132(1), 8–17. https://doi.org/10.1016/j.ygyno.2013.11.008
How many times has this paper been cited?
77 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Europe PMC (PubMed Central): sign in and open the full text from this page.
Who wrote this paper?
Thomas J. Herzog, Deborah Kay Armstrong, Mark F. Brady, Robert Louis Coleman, Mark H. Einstein, Bradley J. Monk, Robert S. Mannel, James Tate Thigpen, Sharee A. Umpierre, Jeannine Villella, Ronald David Alvarez.
What is the DOI of this paper?
10.1016/j.ygyno.2013.11.008, permanently at https://doi.org/10.1016/j.ygyno.2013.11.008. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.